• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢孟多给药后发生血管外溶血。

Extravascular hemolysis following the administration of cefamandole.

作者信息

Branch D R, Berkowitz L R, Becker R L, Robinson J, Martin M, Gallagher M T, Petz L D

出版信息

Am J Hematol. 1985 Feb;18(2):213-9. doi: 10.1002/ajh.2830180213.

DOI:10.1002/ajh.2830180213
PMID:3970014
Abstract

Hemolytic anemia occurred in a 70-year-old female after a five-day course of intravenous cefamandole. The patient's serum contained an IgG antibody which was reactive with red blood cells which had been coated in vitro with cefamandole but not with uncoated cells. An in vitro assay of allogeneic mononuclear phagocytosis of cefamandole-coated red cells sensitized with the patient's anti-cefamandole indicated that the anti-cefamandole could induce significant phagocytosis. The anti-cefamandole was easily inhibited in vitro by cefamandole as well as by a variety of related cephalosporins indicating broad cross-reactivity, with the antigenic site primarily the 7-amino-cephalosporanic acid nucleus. Penicillins could inhibit the anti-cefamandole but only when using concentrations 3-10 X those of cephalosporins. Eleven examples of anti-penicillin tested failed to react with cefamandole-coated red cells. Screening of 344 random sera from hospitalized patients found only five (1.5%) reactive with cefamandole-coated red cells; three of these sera were also reactive with penicillin-coated red cells. The patient's hemolysis subsided following cessation of the drug. This is the first report of anti-cefamandole-induced hemolytic anemia.

摘要

一名70岁女性在静脉注射头孢孟多五天后发生溶血性贫血。患者血清中含有一种IgG抗体,该抗体与体外被头孢孟多包被的红细胞发生反应,但不与未包被的细胞发生反应。对用患者的抗头孢孟多致敏的头孢孟多包被红细胞进行的同种异体单核吞噬细胞体外测定表明,抗头孢孟多可诱导显著的吞噬作用。头孢孟多以及多种相关头孢菌素在体外很容易抑制抗头孢孟多,这表明存在广泛的交叉反应性,抗原位点主要是7-氨基头孢烷酸核。青霉素可以抑制抗头孢孟多,但只有在使用浓度为头孢菌素3至10倍时才有效。对11份抗青霉素检测样本进行检测,结果显示它们与头孢孟多包被的红细胞无反应。对344份住院患者的随机血清进行筛查,发现只有5份(1.5%)与头孢孟多包被的红细胞发生反应;其中3份血清也与青霉素包被的红细胞发生反应。停药后患者的溶血症状消退。这是关于抗头孢孟多诱导的溶血性贫血的首次报告。

相似文献

1
Extravascular hemolysis following the administration of cefamandole.头孢孟多给药后发生血管外溶血。
Am J Hematol. 1985 Feb;18(2):213-9. doi: 10.1002/ajh.2830180213.
2
Auto-immune hemolytic anemia caused by anti-K13.由抗K13引起的自身免疫性溶血性贫血。
Vox Sang. 1979;36(3):174-8. doi: 10.1111/j.1423-0410.1979.tb04419.x.
3
Mechanisms of immune haemolysis: cell-dependent destruction of autologous red blood cells in penicillin-induced haemolytic anaemia.免疫性溶血机制:青霉素诱导的溶血性贫血中自体红细胞的细胞依赖性破坏
Scand J Haematol. 1982 May;28(5):408-16.
4
Penicillin-induced immune hemolytic anemia. Occurrence of massive intravascular hemolysis.青霉素诱发的免疫性溶血性贫血。发生大量血管内溶血。
JAMA. 1975 Aug 4;233(5):432-5.
5
Drug-induced immune hemolytic anemia.药物性免疫性溶血性贫血
Am J Med. 1975 Mar;58(3):398-407. doi: 10.1016/0002-9343(75)90606-3.
6
'Immune complex' mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody.由IgM头孢菌素依赖性抗体介导的“免疫复合物”型血管内溶血。
Transfusion. 1987 Nov-Dec;27(6):460-3. doi: 10.1046/j.1537-2995.1987.27688071694.x.
7
Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.25 例药物诱导免疫性溶血性贫血患者头孢曲松抗体的血清学特征。
Transfusion. 2012 Mar;52(3):602-12. doi: 10.1111/j.1537-2995.2011.03321.x. Epub 2011 Aug 31.
8
Cefotetan-induced immune hemolytic anemia.头孢替坦诱发的免疫性溶血性贫血。
Clin Infect Dis. 1992 Nov;15(5):863-5. doi: 10.1093/clind/15.5.863.
9
A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.一例与血管内免疫性溶血相关的头孢曲松(罗氏芬)诱发的溶血性贫血致死病例。
Transfusion. 1991 Feb;31(2):176-9. doi: 10.1046/j.1537-2995.1991.31291142951.x.
10
Amoxicillin-induced immune hemolysis.阿莫西林诱发的免疫性溶血。
Acta Haematol. 1985;74(4):230-3. doi: 10.1159/000206226.